Microbial Drug Resistance
Scope & Guideline
Illuminating the Path to Effective Antimicrobial Strategies
Introduction
Aims and Scopes
- Mechanisms of Drug Resistance:
Research articles explore the genetic, biochemical, and physiological mechanisms by which bacteria and fungi develop resistance to antimicrobial agents, including beta-lactams, macrolides, and newer antibiotics. - Clinical Implications of Resistance:
The journal emphasizes studies that investigate the clinical consequences of antimicrobial resistance, including treatment failures, infection outcomes, and the implications for public health. - Surveillance and Epidemiology:
Publications include epidemiological studies that track the prevalence and distribution of resistance genes in various environments, including hospitals, communities, and animal populations. - Novel Therapeutic Approaches:
Research on new antimicrobial agents, combination therapies, and alternative treatment strategies is a key focus, showcasing efforts to combat resistance in clinical settings. - Environmental and One Health Perspectives:
The journal also covers studies that assess the environmental impact of resistant pathogens and the interconnectedness of human, animal, and environmental health in the context of antimicrobial resistance.
Trending and Emerging
- Characterization of Resistance Genes and Mobile Elements:
There is a growing emphasis on the characterization of resistance genes, particularly those located on mobile genetic elements such as plasmids, which facilitate the spread of resistance across different bacterial species. - Impact of COVID-19 on Resistance Trends:
Research examining how the COVID-19 pandemic has influenced antimicrobial resistance patterns, treatment practices, and infection control measures has gained significant attention. - Use of Advanced Genomic Techniques:
The application of whole-genome sequencing and other genomic techniques to analyze resistance mechanisms and track outbreaks is becoming increasingly prevalent in published studies. - Environmental Resistance Dynamics:
Emerging research focuses on the dynamics of antimicrobial resistance in environmental contexts, including wastewater, agricultural settings, and wildlife, highlighting the importance of a One Health approach. - Innovative Therapeutic Strategies:
There is a rising interest in exploring novel therapeutic strategies, including the use of bacteriophages, antimicrobial peptides, and combination therapies, to overcome drug resistance.
Declining or Waning
- Antibiotic Stewardship in Specific Settings:
Although antibiotic stewardship remains important, there has been a noticeable decline in studies focusing solely on stewardship practices within specific healthcare settings, as more comprehensive and integrated approaches are being adopted. - Basic Laboratory Techniques for Resistance Detection:
Research centered around traditional laboratory methods for detecting resistance, such as disk diffusion or standard broth microdilution, appears to be less frequent, as newer molecular and rapid testing methods gain traction. - Single-Pathogen Studies:
The trend has shifted towards multi-pathogen studies and broader environmental assessments, leading to a decrease in publications focusing exclusively on single-pathogen resistance profiles. - Global Surveys of Resistance Patterns:
While still relevant, the frequency of global surveys of resistance patterns has diminished, possibly due to the increasing focus on localized studies that address specific regional challenges.
Similar Journals
JOURNAL OF CLINICAL MICROBIOLOGY
Transforming Knowledge into Clinical PracticeJOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.
Infection and Drug Resistance
Championing open access for groundbreaking research in infection control.Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.
BMC MICROBIOLOGY
Connecting minds through groundbreaking microbiology insights.BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
Empowering Knowledge in Food MicrobiologyINTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY is a leading journal in the field of food safety and microbiology, published by Elsevier. With an impressive impact factor and a distinguished position, it ranks in the top quartile for both Food Science and Medicine, as well as holding a strong presence in Microbiology and Safety, Risk, Reliability, and Quality categories. The journal provides a vital platform for researchers, professionals, and students to disseminate and discuss innovative research findings and applications that address the complexities of food microbiology. Operating from its headquarters in the Netherlands, this journal not only facilitates access to high-quality scholarly articles but also encourages the development of interdisciplinary approaches to tackle current challenges in food safety and public health. Since its inception in 1984, the journal has continually evolved, ensuring that it remains at the forefront of scientific inquiry, making it a crucial resource for anyone engaged in the food sciences.
CRITICAL REVIEWS IN MICROBIOLOGY
Navigating the Complexities of Microbial LifeCRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.
Reviews and Research in Medical Microbiology
Catalyzing Change in the Study of Infectious DiseasesReviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.
INDIAN JOURNAL OF MICROBIOLOGY
Empowering Discoveries in Microbial ScienceINDIAN JOURNAL OF MICROBIOLOGY, published by Springer, serves as a vital platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0046-8991 and an E-ISSN of 0973-7715, this esteemed journal invites contributions that span various disciplines within microbiology, encompassing both fundamental studies and applied research that can impact health, environment, and industry. Recognized in the Q3 category in Microbiology for 2023, and ranking #80 out of 182 in Scopus’ Microbiology category, it reflects its commitment to quality and significance in the academic community. Authors and researchers benefit from the journal's comprehensive review process, which enhances the visibility and reach of their work. While no open access options are currently offered, the INDIAN JOURNAL OF MICROBIOLOGY remains a premier choice for those aiming to contribute to the ongoing dialogue in microbiological studies, ensuring that knowledge continues to evolve and thrive.
Microorganisms
Exploring the unseen world of microorganisms.Microorganisms is a leading open-access journal published by MDPI based in Switzerland, catering specifically to the rapidly evolving fields of microbiology and virology. Since its inception in 2013, the journal aims to foster the dissemination of high-quality research through its comprehensive and interdisciplinary platform, with a particular focus on both fundamental and applied microbiological sciences. Contributing to its esteemed reputation, Microorganisms holds a commendable Q2 ranking in the categories of Microbiology and Virology, as well as in Medical Microbiology, highlighting its significance in the academic community. With a consistent impact, evidenced by its rankings in Scopus—such as rank #25 in Virology and #56 in Microbiology—the journal serves as an invaluable resource for researchers, professionals, and students looking to stay at the forefront of microbiological research. As an open-access journal, Microorganisms ensures that vital research findings are readily available to a global audience, promoting collaboration and innovation in the study of microbial life and its implications for health and disease.
Lancet Microbe
Pioneering Discoveries in Global Health ChallengesThe Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.
Revista Espanola de Quimioterapia
Pioneering Open Access for Enhanced Scientific CollaborationThe Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.